The Poison Help campaign is the
vehicle for introducing the national toll-free telephone number for
use in poisoning emergencies and providing poison prevention
information. The goal of the Poison Help General Population Survey
is to measure the campaign’s current performance. The audience for
the campaign is very broad—any person at any time is a potential
user of poison center services. A nationally representative
tracking survey, required by law for campaign evaluation and
reporting, is conducted approximately every 5 years among 2,000
U.S. adult households. The next survey will be conducted by Fall
2017.
In the 2017 survey instrument,
questions deemed unnecessary (because information can be gleaned
from other questions) were removed, and included questions related
to the new additional campaign priorities (opioid, that is,
prescription pain medication and heroin, overdose). In light of the
current need to use of dual-frame landline and mobile phone,
sampling methodologies to maintain high quality nationally
representative survey sampling, standard questions related to
landline vs. cell phone utilization were added for weighting and
quality control purposes. Between the previously approved and
conducted study in 2011 and this current initiative, there is a
minimal increase in burden, from 370 to 374.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.